Form 4: Interparfums Inc. Director Gabai-Pinsky Acquires Stock Options
SEC Form 4
Director Veronique Gabai-Pinsky reports acquisition of stock options in Interparfums Inc.
Summary
- Veronique Gabai-Pinsky, a director of Interparfums Inc., filed a Form 4 disclosing changes in beneficial ownership.
- The report details the acquisition of option rights to buy Interparfums Inc. common stock.
- The options have various exercise prices and expiration dates, ranging from December 2028 to December 2030.
- The exercise prices for the options range from $62.18 to $147.71.
- All options are directly owned by Gabai-Pinsky.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director. While insider confidence is generally positive, this is a standard part of compensation.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Option grants are a common form of executive compensation in the industry.
Comparison to Industry Standards
- Comparing the option exercise prices and vesting schedules to those of executives at comparable companies like Coty Inc. or Estee Lauder Companies Inc. could provide context on the competitiveness of Interparfums' compensation packages.
- Analyzing the ratio of options granted to outstanding shares relative to industry peers can offer insights into potential dilution effects.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/01/2022 | Date exercisable for some options with an expiration date of 01/31/2026 and an exercise price of $62.18. |
| 02/01/2023 | Date exercisable for some options with an expiration date of 01/31/2026 and an exercise price of $62.18. |
| 02/01/2024 | Date exercisable for some options with an expiration date of 01/31/2026 and an exercise price of $62.18. |
| 12/31/2024 | Date of the transaction and date exercisable for some options with an expiration date of 12/30/2030 and an exercise price of $130.60. |
| 12/29/2024 | Date exercisable for some options with an expiration date of 12/28/2029 and an exercise price of $147.71. |
| 01/03/2025 | Date of the Form 4 filing. |
| 12/31/2025 | Date exercisable for some options with an expiration date of 12/30/2030 and an exercise price of $130.60. |
| 12/31/2026 | Date exercisable for some options with an expiration date of 12/30/2030 and an exercise price of $130.60. |
| 12/31/2027 | Date exercisable for some options with an expiration date of 12/30/2030 and an exercise price of $130.60. |
| 12/31/2028 | Date exercisable for some options with an expiration date of 12/30/2030 and an exercise price of $130.60. |
| 12/31/2029 | Date exercisable for some options with an expiration date of 12/30/2030 and an exercise price of $130.60. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.